18F-FAPI

N/A

Report date: 2025/09/30 15:22:18
NME

Base Information

Drug Name18F-FAPI
Drug Alias Name18F-FAPI[18F]F-FAPIAl18F-NOTA-FAPI18F-FAPI-04
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsCholangiocarcinomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAffiliated Hospital of Jiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesErasmus Medical CenterAffiliated Hospital of Jiangnan University
Inactive CompaniesN/A
Active IndicationsCholangiocarcinomaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A